<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03736226</url>
  </required_header>
  <id_info>
    <org_study_id>S2424</org_study_id>
    <nct_id>NCT03736226</nct_id>
  </id_info>
  <brief_title>A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China</brief_title>
  <official_title>A Post-Approval, Single-Arm Study of the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, observational, single-arm, open-label, multicenter, post-approval study. To
      compile real-world clinical outcomes data for the SYNERGYTM MONORAILTM Everolimus-Eluting
      Platinum Chromium Coronary Stent System (SYNERGYTM Stent System) in real-world clinical
      practice in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective, open-label, multi-center study is designed to provide post-market
      surveillance information on the SYNERGY Stent System. The study will evaluate clinical
      outcomes of subjects receiving the SYNERGY™ stents over 5 years in a real world setting
      according to post approval requirements by China government.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>MACE rate</measure>
    <time_frame>12 months</time_frame>
    <description>endpoints will be assessed post stent implant</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SYNERGYTM Stent System</intervention_name>
    <description>no intervention design in the study</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        &quot;all comers&quot; study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Subject must be at least 18 years of age

               -  Subject understands and provides written informed consent

               -  Subject who is clinically indicated and will have an attempt of at least one
                  SYNERGYTM stent OR Subject who is clinically indicated and was implanted with at
                  least one SYNERGYTM stent

               -  Subject is willing to comply with all protocol-required follow-up evaluation

        Exclusion Criteria:

          -  Exclusion criteria are not required in this study which is an &quot;all comers&quot; study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhiyu Zeng</last_name>
    <role>Study Chair</role>
    <affiliation>Boston Scientific Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuwei ZHANG</last_name>
    <phone>+86 10 85216440</phone>
    <email>zhany18@bsci.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JUNBO GE</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>November 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

